Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP).
D002353:Carrier State; D002487:Centers for Disease Control and Prevention, U.S.; D005260:Female; D006506:Hepatitis A / Q000517:prevention & control; D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D017325:Hepatitis B Vaccines; D006526:Hepatitis C / Q000517:prevention & control; D003699:Hepatitis D / Q000517:prevention & control; D006525:Hepatitis, Viral, Human / Q000401:mortality / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007116:Immunization, Passive; D008297:Male; D011159:Population Surveillance; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D015995:Prevalence; D012749:Sexually Transmitted Diseases / Q000635:transmission; D014481:United States / Q000453:epidemiology; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage
D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines